StockClub
ZYBTZhengye Biotechnology Holding Limited$ --
Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

ZYBT

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2024/12 Filed: 2025-07-03

Total Assets

account_balance
493.2M CNY
No comparison

Shareholders' Equity

savings
284M CNY
No comparison

Equity Ratio

pie_chart
57.6%
No comparison

Book Value Per Share

paid
5.99CNY
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityOtherNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
806040200
2021
2022
2023
2024

Balance Sheet Details

Item
2021
2022
2023
2024
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
18.60M
18.60M
1.43M
88.52M
58.22M
2,000
177.57M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
22.78M
255.16M
255.16M
0
0
26.75M
470.47M
315.68M
493.25M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
42.96M
81.63M
81.63M
3.69M
3.28M
135.91M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
4.80M
86.43M
0
0
67.83M
4.80M
140.71M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
8,000
0
203.15M
48.15M
32.65M
0
0
283.96M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.